510(k) · Cleared
ClearedTaper 2 Porous Femoral Stem
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Biomet, Inc. · JDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented
Cleared on Jun 29, 2005 as substantially equivalent to K921301 (Biomet, Inc., 1994) and 1 other predicate after a 127-day review. Its family tree reaches back 1 generation to 1994. 85 later devices descend from it.
- Decided
- Jun 29, 2005
- Review
- 127 days
- Class
- Class II
- Product code
- JDI
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K921301 (1994). 2 ancestors in all. 85 later devices descend from it, 1 citing it directly.
- Root · 1 generation backK921301 Taperloc Femoral Stem and Universal Acetabular ComBiomet, Inc. · 1994
- This deviceK050441 Taper 2 Porous Femoral StemBiomet, Inc. · 2005
- Descendant · cites it directly · 84 of its ownK062994 Lateralized Taperloc Microplasty Femoral ComponentsBiomet Manufacturing Corp · 2007
- Descendant · 2 generations on · 44 of its ownK072417 Smith & Nephew Mis Hip StemSmith & Nephew, Inc. · 2008 · Recalled
- Descendant · 2 generations on · 34 of its ownK110400 Taperloc Complete Microplasty StemBiomet Manufacturing Corp · 2011
- Descendant · 3 generations on · 19 of its ownK080625 Smith & Nephew Mis Hip Stem with StiktiteSmith & Nephew, Inc. · 2008 · Recalled
- Descendant · 4 generations on · 16 of its ownK103256 Smith & Nephew SMF Hip StemSmith & Nephew, Inc. · 2011 · Recalled
Showing 5 of 85 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 85 · See all- K062994Lateralized Taperloc Microplasty Femoral ComponentsBiomet Manufacturing Corp · 2007 · cites it directly84descendants
- K072417Smith & Nephew Mis Hip StemSmith & Nephew, Inc. · 2008 · 2 generations on44descendants
- K110400Taperloc Complete Microplasty StemBiomet Manufacturing Corp · 2011 · 2 generations on34descendants
- K080625Smith & Nephew Mis Hip Stem with StiktiteSmith & Nephew, Inc. · 2008 · 3 generations on19descendants
- K103256Smith & Nephew SMF Hip StemSmith & Nephew, Inc. · 2011 · 4 generations on16descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K921301 | Taperloc Femoral Stem and Universal Acetabular Com | Biomet, Inc. | 1994 | — |
| 0 (this device) | K050441 | Taper 2 Porous Femoral Stem | Biomet, Inc. | 2005 | — |
| +1 | K062994 | Lateralized Taperloc Microplasty Femoral Components | Biomet Manufacturing Corp | 2007 | — |
| +2 | K072417 | Smith & Nephew Mis Hip Stem | Smith & Nephew, Inc. | 2008 | 1 |
| +2 | K110400 | Taperloc Complete Microplasty Stem | Biomet Manufacturing Corp | 2011 | — |
| +3 | K080625 | Smith & Nephew Mis Hip Stem with Stiktite | Smith & Nephew, Inc. | 2008 | 1 |
| +4 | K103256 | Smith & Nephew SMF Hip Stem | Smith & Nephew, Inc. | 2011 | 2 |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
| 2008 | 3 | 0 |
| 2010 | 2 | 0 |
| 2011 | 3 | 0 |
| 2012 | 8 | 0 |
| 2013 | 7 | 0 |
| 2014 | 5 | 0 |
| 2015 | 2 | 0 |
| 2016 | 4 | 0 |
| 2017 | 7 | 0 |
| 2018 | 4 | 0 |
| 2019 | 4 | 0 |
| 2020 | 1 | 0 |
| 2021 | 4 | 0 |
| 2022 | 4 | 0 |
| 2023 | 5 | 0 |
| 2024 | 8 | 0 |
| 2025 | 4 | 0 |
| 2026 | 9 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in JDI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new JDI device
- #1 K253515 Zimmer Biomet OSS™ Orthopedic Salvage System…score 15.2 · 12 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K921301 | Taperloc Femoral Stem and Universal Acetabular ComSummary page 2…R§888.3390), Product Code: KWY Legally Marketed Devices To Which Substantial Equivalence Is Claimed: TaperLoc® Porous and Reduced Distal Femoral Stems - Biomet (K921301) Mayo® Conservative Hip Prosthesis - Zimmer Inc. (K943230)… | 1994 |
| * | K943230 | Mayo Hip ProsthesisSummary page 2…Substantial Equivalence Is Claimed: TaperLoc® Porous and Reduced Distal Femoral Stems - Biomet (K921301) Mayo® Conservative Hip Prosthesis - Zimmer Inc. (K943230) to provide Device Description… | 1997 |
What descends from it? (85)
See all 851 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K062994 | Lateralized Taperloc Microplasty Femoral Components | 2007 | 84 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All JDI devicesJDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · JDI
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · JDI
59in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · JDI
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · JDI
1,644in 2025
MAUDE reports naming product code JDI, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 81 | 26 | 696 |
| 2008 | 5 | 96 | 6 | 810 |
| 2009 | 3 | 65 | 3 | 964 |
| 2010 | 0 | — | 3 | 2,040 |
| 2011 | 2 | — | 5 | 3,160 |
| 2012 | 4 | 167 | 4 | 5,122 |
| 2013 | 3 | 176 | 11 | 5,206 |
| 2014 | 3 | 98 | 3 | 4,968 |
| 2015 | 3 | 190 | 1 | 4,906 |
| 2016 | 4 | 166 | 5 | 3,995 |
| 2017 | 1 | — | 5 | 6,135 |
| 2018 | 1 | — | 1 | 6,728 |
| 2019 | 2 | — | 1 | 7,407 |
| 2020 | 7 | 247 | 77 | 4,015 |
| 2021 | 3 | 162 | 0 | 3,170 |
| 2022 | 3 | 69 | 0 | 1,978 |
| 2023 | 2 | — | 0 | 1,635 |
| 2024 | 3 | 59 | 0 | 1,821 |
| 2025 | 1 | — | 1 | 1,644 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
The Taper 2 Porous Femoral Stem is indicated for use in patients requiring total hip replacement due to the following: * Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis * Rheumatoid arthritis * Correction of functional deformity * Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques * Revision of previously failed…
Read the full statement (225 words)
The Taper 2 Porous Femoral Stem is indicated for use in patients requiring total hip replacement due to the following:
* Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
* Rheumatoid arthritis
* Correction of functional deformity
* Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques
* Revision of previously failed femoral head resurfacing component
Taper 2 Porous Femoral Stems are intended for uncemented use only.
Specific indications for compatible components that can be used with the above femoral stems include:
Constrained Liners (LK030047)
Constrained liners are intended for general use in skeletally mature individuals undergoing primary and/or revision surgery at high risk of hip dislocation due to history of prior dislocation, joint or bone loss, soft tissue laxity, neuromuscular disease, or intra-operative instability and for whom all other options to constrained acetabular components have been considered.
OSS / Salvage Systems / Total Femur (K974558, K002757, K021380, K033871)
Salvage/Oncology Hip and Total Femur components are also indicated for cases of ligament deficiency, tumor resection, trauma and revision of unsuccessful osteotomy or arthrodesis.
Interlocking Stems (K990830, K042774)
Interlocking hip stems are indicated for non-cemented application in cases of revision, trauma, fracture, oncology or other situations where severe proximal bone loss may compromise the fixation and stability of a standard type hip replacement prosthesis.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K050441 · printed Nov 3, 2026
Cite this page
510(k) Report. “K050441: Taper 2 Porous Femoral Stem.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K050441
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026